Vestal Point Capital, LP

Vestal Point Capital, LP reported 63 holdings worth US$3.87B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Vestal Point Capital, LP reported 63 holdings worth US$3.87B as of Sep 30, 2026. Largest: Abivax SA, Neurocrine Biosciences, Inc. and BioMarin Pharmaceutical Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
63
Value as reported
US$3.87B

The filing in full

CompanySharesValue as reported% of portfolio
Abivax SA3.96MUS$392M10.1%
Neurocrine Biosciences, Inc.2.5MUS$355M9.2%
BioMarin Pharmaceutical Inc.5.53MUS$332M8.6%
Arrowhead Pharmaceuticals, Inc.4.82MUS$315M8.1%
Insmed Incorporated2.73MUS$311M8.0%
United Therapeutics Corporation475KUS$257M6.6%
Nurix Therapeutics, Inc.7.03MUS$167M4.3%
Tarsus Pharmaceuticals, Inc.2.03MUS$160M4.1%
Enliven Therapeutics, Inc.3.23MUS$148M3.8%
Disc Medicine, Inc.1.64MUS$107M2.8%
Bicara Therapeutics Inc.5.53MUS$103M2.7%
Dyne Therapeutics, Inc.6.2MUS$99.9M2.6%
Taysha Gene Therapies, Inc.18MUS$87.9M2.3%
Monte Rosa Therapeutics, Inc.7.13MUS$85.1M2.2%
Globus Medical, Inc.915KUS$68.5M1.8%
Crescent Biopharma, Inc.3MUS$43.8M1.1%
Zimmer Biomet Holdings, Inc.475KUS$42.2M1.1%
Travere Therapeutics, Inc.600KUS$35.3M0.91%
Arcus Biosciences, Inc.1.3MUS$33.6M0.87%
Xenon Pharmaceuticals Inc.850KUS$31.6M0.82%
Nektar Therapeutics510KUS$30.9M0.80%
Bright Minds Biosciences Inc.545KUS$27.2M0.70%
BridgeBio Pharma, Inc.400KUS$26.3M0.68%
Immunocore Holdings plc850KUS$25.7M0.67%
Insulet Corporation175KUS$22.8M0.59%
Trevi Therapeutics, Inc.1.5MUS$21.4M0.55%
Sanofi SA500KUS$20.6M0.53%
Savara, Inc.3.3MUS$17M0.44%
SpyGlass Pharma, Inc.640KUS$16.6M0.43%
Zymeworks Inc.600KUS$15.9M0.41%
Cogent Biosciences, Inc.475KUS$15.2M0.39%
Solid Biosciences Inc.2.08MUS$15.1M0.39%
Lexeo Therapeutics, Inc.4.32MUS$14.6M0.38%
Avalo Therapeutics, Inc.800KUS$12.3M0.32%
Zenas BioPharma, Inc.395KUS$10.7M0.28%
Evommune, Inc.1.25MUS$10.3M0.27%
Viking Therapeutics, Inc.290KUS$9.45M0.24%
Stoke Therapeutics, Inc.345KUS$8.97M0.23%
Tectonic Therapeutic, Inc.360KUS$8.38M0.22%
Zura Bio Limited1.86MUS$7.74M0.20%
Glaukos Corporation45,000US$7.39M0.19%
Kailera Therapeutics, Inc.625KUS$7.14M0.18%
Anteris Technologies Global Corp.850KUS$6.6M0.17%
Rezolute, Inc.1.46MUS$6.02M0.16%
First Tracks Biotherapeutics, Inc.170KUS$6.02M0.16%
Voyager Therapeutics, Inc.2.17MUS$5.8M0.15%
Maze Therapeutics, Inc.175KUS$4.76M0.12%
Olema Pharmaceuticals, Inc.420KUS$3.63M0.09%
Palisade Bio, Inc.2.5MUS$3.38M0.09%
Neurogene Inc.115KUS$3.2M0.08%
iBio, Inc.2.6MUS$3.07M0.08%
ArriVent BioPharma, Inc.100KUS$3.03M0.08%
OnKure Therapeutics, Inc.1.09MUS$2.96M0.08%
CytomX Therapeutics, Inc.535KUS$1.46M0.04%
Aprea Therapeutics, Inc.350KUS$263K<0.01%
Rapport Therapeutics, Inc.0US$00.00%
Regeneron Pharmaceuticals, Inc.0US$00.00%
Repligen Corporation0US$00.00%
Revolution Medicines, Inc.0US$00.00%
Sagimet Biosciences Inc. - Series A0US$00.00%
Surrozen, Inc.0US$00.00%
Tenax Therapeutics, Inc.0US$00.00%
Abbott Laboratories0US$00.00%
Alto Neuroscience, Inc.0US$00.00%
Beta Bionics, Inc.0US$00.00%
BioCryst Pharmaceuticals, Inc.0US$00.00%
Bristol-Myers Squibb Company0US$00.00%
Damora Therapeutics, Inc.0US$00.00%
GE HealthCare Technologies Inc.0US$00.00%
Madrigal Pharmaceuticals, Inc.0US$00.00%
Monopar Therapeutics Inc.0US$00.00%
Myriad Genetics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related